Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study-Reference-Cited by-同舟云学术

Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study

Published:2022-08-11 Issue:9 Volume:12 Page:2105-2115
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Li Gaojie,Gu Yuanxia,Zou Qin,Wang Yiyi,Xiao Yue,Xia Dengmei,Zhan Tongying,Zhou Xingli,Wang Qian,Yan Wei,Li Wei^ORCID

Funder

Sichuan Province Science and Technology Support Program

West China Hospital, Sichuan University

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-022-00787-x.pdf

Reference25 articles.

1. National Psoraisis Foundation. https://www.psoriasis.org/psoriasis-statistics/. Accessed 1 October 2015.

2. Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205–12.

3. Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol. 2012;22(5):663–7.

4. Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD–NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073–113.

5. Papp K, Thaçi D, Marcoux D, et al. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial. Lancet. 2017;390(10089):40–9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective;Dermatology and Therapy;2023-09-23

2. LARP7 alleviates psoriasis symptoms in mice by regulating the SIRT1/NF-κκB signaling pathway;Allergologia et Immunopathologia;2023-01-01

3. Incidence, Risk Factors, and Consequences of Human Alphaherpesvirus Infections in Patients With Psoriasis Who Initiate Methotrexate or Biologic Agents;The Journal of Infectious Diseases;2022-09-13